IConquerMS™ - a Patient-Powered Research Network for Multiple Sclerosis
NCT02486562 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 20000
Last updated 2025-02-18
Summary
iConquerMS™ is a research initiative developed by and for people with multiple sclerosis (MS) to contribute their health data and ideas to advance and accelerate research into MS. iConquerMS welcomes adults with MS and others interested in advancing MS research, children and teens with MS and their family members (via iConquerMS Kids \& Teens) and MS caregivers (via iConquerMS Caregivers) to participate.
Conditions
Sponsors & Collaborators
-
Patient-Centered Outcomes Research Institute
collaborator OTHER -
Ogilvy
collaborator UNKNOWN -
Arizona State University
collaborator OTHER -
Accelerated Cure Project for Multiple Sclerosis
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-11-30
- Primary Completion
- 2030-10-31
- Completion
- 2036-10-31
Countries
- United States
Study Locations
More Related Trials
-
Digital Cognition in Multiple Sclerosis
NCT03569618 ·Status: COMPLETED ·Phase: NA
-
An Observational Biomarker Study in Multiple Sclerosis (MS) Patients
NCT05663853 ·Status: COMPLETED
-
Autologous Mesenchymal Stem Cell (MSC) Transplantation in MS
NCT00813969 ·Status: COMPLETED ·Phase: PHASE1
-
An Observational Pilot Study of Lumosity Computerized Cognitive Training in Subjects With Multiple Sclerosis
NCT02612935 ·Status: COMPLETED
-
Remote MS Care in Antwerp
NCT06179758 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Phase 2 Extension Trial in Patients With Relapsing-Remitting Multiple Sclerosis (RRMS)
NCT01226745 ·Status: TERMINATED ·Phase: PHASE2
-
Care in Multiple Sclerosis (MS)
NCT07011914 ·Status: RECRUITING
-
T Cell Profiling in Patients With Multiple Sclerosis
NCT04789551 ·Status: WITHDRAWN
-
Characterization of White Blood Cells Sub-populations From Multiple Sclerosis Patients.
NCT03486665 ·Status: UNKNOWN
-
Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis
NCT04798651 ·Status: RECRUITING ·Phase: NA
-
Photobiomodulation Therapy in Persons With Multiple Sclerosis
NCT03691766 ·Status: COMPLETED ·Phase: NA
-
Study of myMS in Participants With a Diagnosis of Multiple Sclerosis
NCT03111394 ·Status: COMPLETED
-
CogMS - A Real-world Study Into Cognitive Impairment in People With Multiple Sclerosis
NCT05671055 ·Status: COMPLETED
-
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
NCT02807285 ·Status: NO_LONGER_AVAILABLE
-
Neurorehabilitation of Cognitive Deficits in Multiple Sclerosis Using an Adaptive Cognitive Exergame - Randomized, Controlled, Multi-center Clinical Trial
NCT07086950 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Increasing Physical Activity for Adults With Multiple Sclerosis (MS)
NCT06270641 ·Status: RECRUITING ·Phase: NA
-
Biobank For MS And Other Demyelinating Diseases
NCT00445367 ·Status: ACTIVE_NOT_RECRUITING
-
Aerobic Exercises for Multiple Sclerosis
NCT04545372 ·Status: COMPLETED ·Phase: NA
-
Evaluating Multiple Sclerosis Patients ShOWing A GEnomic Signature of Therapy Response
NCT03316404 ·Status: COMPLETED
-
Study to Explore the Mechanism of Action of Ocrelizumab and B-Cell Biology in Participants With Relapsing Multiple Sclerosis (RMS) or Primary Progressive Multiple Sclerosis (PPMS)
NCT02688985 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Usability and Value of Integrated Digital Solutions in Medical Care of Participants With Multiple Sclerosis
NCT05949580 ·Status: SUSPENDED
-
Immune Profiling During Ocrelizumab Treatment in Multiple Sclerosis
NCT03138525 ·Status: COMPLETED
-
A Pilot Study to Assess microRNA Biomarkers in Early and Later Stage Multiple Sclerosis
NCT01737372 ·Status: COMPLETED
-
COVID-19 Booster Vaccination in Persons With Multiple Sclerosis
NCT05081271 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Cellular microRNA Signatures in Multiple Sclerosis
NCT05290688 ·Status: UNKNOWN ·Phase: NA